English
Russian
Transurethral resection of prostate for bladder outlet obstruction among patients with type 2 diabetes mellitus DOI: https://doi.org/10.29188/2222-8543-2024-17-1-94-99
- Volkov S.N. – PhD, Head of the Department of Urology and Andrology of the Federal State Budgetary Institution NMIC of Endocrinology; Moscow, Russia; RSCI Author ID 1121560, https://orcid.org/0000-0002-2049-2191
- Mikheev R.K. – postgraduate student of the Federal State Budgetary Institution NMIC of Endocrinology; Moscow, Russia; RSCI Author ID 945872; https://orcid.org/0000-0001-5826-3186
- Grigoryan O.R. – Dr. Sci., Professor, Chief Researcher of the Department of Endocrine Gynecology of the Federal State Budgetary Institution NMIC of Endocrinology, Professor of the Department of Reproductive Medicine and Surgery of the Russian University of Medicine; Moscow, Russia; RSCI Author ID 30398, https://orcid.org/0000-0003-4979-7420
- Tereshchenko V.I. – urologist-andrologist of the Federal State Budgetary Institution of the National Research Institute of Endocrinology; Moscow, Russia; https://orcid.org/0000-0002-4478-5968
- Stepanchenko V.S. – urologist-andrologist of the Federal State Budgetary Institution of the National Research Institute of Endocrinology; Moscow, Russia; https://orcid.org/0000-0003-2799-2241
- Andreeva E.N. – Dr. Sci., Professor, Head of the Department of Endocrine Gynecology, Director of the Institute of Reproductive Medicine of the Federal State Budgetary Institution NMIC of Endocrinology; Moscow, Russia; RSCI Author ID 675709, https://orcid.org/0000-0001-8425-0020
237 Introduction. Bladder obstruction caused by benign prostatic hyperplasia (BPH) is common disease among males with diabetes mellitus (T2DM).
Objective. To evaluate lower urinary tract symptoms (LUTS) and clinical outcomes among patients with/without DM2T after undergoing transurethral resection prostate (TURP).
Materials and methods. Retrospective study based on medical data throughout 1,5 years (2021–2022 гг.) and participation of 48 diabetic and non-diabetic patients with persistent LUTS who also have underwent TURP for BPH.
Results. Patients with DM2T show higher prevalence of cardiovascular diseases (р=0,01). They also show higher need for alpha-blockers during 1-12 months after TURP for urinary dysorders (OR=5,5, 95% CI: 1,42–21,30, р=0,01).
Discussion. Wide-population prospective clinical studies are needed for creating of effective personalized strategies.
Conclusion. Patients with T2DM more often need alpha-blockers within 1-12 months after TURP. T2DM leads to higher rate of post-surgery urinary retention and worse results compared with non-diabetic patients.
| Attachment | Size |
|---|---|
| Download | 198.75 KB |
Other issue articles
